Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1988 November; 82(5): 1803–1806.
PMCID: PMC442752

Genetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia.


Abetalipoproteinemia (ABL) is a recessive disorder in which affected individuals have extremely low or undetectable levels of serum apo B-containing lipoproteins. Using restriction fragment length polymorphisms, we have studied two families, each with two children with classical ABL born of normal parents. In each of these families, the two affected children have inherited different apo B alleles from at least one parent, whereas the siblings would be anticipated to share common alleles if this disorder were due to an apo B gene mutation. This linkage study shows that in these families, the apo B gene is discordant with ABL and therefore the disorder is caused by a defect in another gene, which is important for the normal synthesis or secretion of apo B-containing lipoproteins from both the liver and intestine.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (757K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Kayden HJ. Abetalipoproteinemia. Annu Rev Med. 1972;23:285–296. [PubMed]
  • Muller DP, Lloyd JK, Wolff OH. Vitamin E and neurological function. Lancet. 1983 Jan 29;1(8318):225–228. [PubMed]
  • Biemer JJ, McCammon RE. The genetic relationship of abetalipoproteinemia and hypobetalipoproteinemia: a report of the occurence of both diseases within the same family. J Lab Clin Med. 1975 Apr;85(4):556–565. [PubMed]
  • Ross RS, Gregg RE, Law SW, Monge JC, Grant SM, Higuchi K, Triche TJ, Jefferson J, Brewer HB., Jr Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level. J Clin Invest. 1988 Feb;81(2):590–595. [PMC free article] [PubMed]
  • Young SG, Bertics SJ, Curtiss LK, Witztum JL. Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia. J Clin Invest. 1987 Jun;79(6):1831–1841. [PMC free article] [PubMed]
  • Young SG, Bertics SJ, Curtiss LK, Dubois BW, Witztum JL. Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. J Clin Invest. 1987 Jun;79(6):1842–1851. [PMC free article] [PubMed]
  • Collins DR, Knott TJ, Pease RJ, Powell LM, Wallis SC, Robertson S, Pullinger CR, Milne RW, Marcel YL, Humphries SE, et al. Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia. Nucleic Acids Res. 1988 Sep 12;16(17):8361–8375. [PMC free article] [PubMed]
  • Whayne TF, Alaupovic P, Curry MD, Lee ET, Anderson PS, Schechter E. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis. 1981 Jun;39(3):411–424. [PubMed]
  • Muller DP, Lloyd JK, Bird AC. Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Arch Dis Child. 1977 Mar;52(3):209–214. [PMC free article] [PubMed]
  • Muller DP, Lloyd JK. Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia. Ann N Y Acad Sci. 1982;393:133–144. [PubMed]
  • Thrift RN, Forte TM, Cahoon BE, Shore VG. Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions. J Lipid Res. 1986 Mar;27(3):236–250. [PubMed]
  • Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW, Jr, Rary JM. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1245–1249. [PubMed]
  • Barni N, Talmud PJ, Carlsson P, Azoulay M, Darnfors C, Harding D, Weil D, Grzeschik KH, Bjursell G, Junien C, et al. The isolation of genomic recombinants for the human apolipoprotein B gene and the mapping of three common DNA polymorphisms of the gene--a useful marker for human chromosome 2. Hum Genet. 1986 Aug;73(4):313–319. [PubMed]
  • Talmud PJ, Barni N, Kessling AM, Carlsson P, Darnfors C, Bjursell G, Galton D, Wynn V, Kirk H, Hayden MR, et al. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis. 1987 Sep;67(1):81–89. [PubMed]
  • Darnfors C, Nilsson J, Protter AA, Carlsson P, Talmud PJ, Humphries SE, Whalström J, Wiklund O, Bjursell G. RFLPs for the human apolipoprotein B gene: HincII and PvuII. Nucleic Acids Res. 1986 Sep 11;14(17):7135–7135. [PMC free article] [PubMed]
  • Kessling AM, Horsthemke B, Humphries SE. A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet. 1985 Oct;28(4):296–306. [PubMed]
  • Knott TJ, Wallis SC, Pease RJ, Powell LM, Scott J. A hypervariable region 3' to the human apolipoprotein B gene. Nucleic Acids Res. 1986 Nov 25;14(22):9215–9216. [PMC free article] [PubMed]
  • Glickman RM, Green PH, Lees RS, Lux SE, Kilgore A. Immunofluorescence studies of apolipoprotein B in intestinal mucosa. Absence in abetalipoproteinemia. Gastroenterology. 1979 Feb;76(2):288–292. [PubMed]
  • Levy E, Marcel YL, Milne RW, Grey VL, Roy CC. Absence of intestinal synthesis of apolipoprotein B-48 in two cases of abetalipoproteinemia. Gastroenterology. 1987 Nov;93(5):1119–1126. [PubMed]
  • Dullaart RP, Speelberg B, Schuurman HJ, Milne RW, Havekes LM, Marcel YL, Geuze HJ, Hulshof MM, Erkelens DW. Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia. J Clin Invest. 1986 Nov;78(5):1397–1404. [PMC free article] [PubMed]
  • Lackner KJ, Monge JC, Gregg RE, Hoeg JM, Triche TJ, Law SW, Brewer HB., Jr Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia. J Clin Invest. 1986 Dec;78(6):1707–1712. [PMC free article] [PubMed]
  • Olofsson SO, Bjursell G, Boström K, Carlsson P, Elovson J, Protter AA, Reuben MA, Bondjers G. Apolipoprotein B: structure, biosynthesis and role in the lipoprotein assembly process. Atherosclerosis. 1987 Nov;68(1-2):1–17. [PubMed]
  • Cardin AD, Witt KR, Chao J, Margolius HS, Donaldson VH, Jackson RL. Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J Biol Chem. 1984 Jul 10;259(13):8522–8528. [PubMed]
  • Vauhkonen M, Viitala J, Parkkinen J, Rauvala H. High-mannose structure of apolipoprotein-B from low-density lipoproteins of human plasma. Eur J Biochem. 1985 Oct 1;152(1):43–50. [PubMed]
  • Huang G, Lee DM, Singh S. Identification of the thiol ester linked lipids in apolipoprotein B. Biochemistry. 1988 Mar 8;27(5):1395–1400. [PubMed]
  • Lander ES, Botstein D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science. 1987 Jun 19;236(4808):1567–1570. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation